713-442-0427
Ayub Hussain, MD, FACG, FACP
9110 Katy Freeway,
Houston,
TX
77055
-
About the Provider
-
Education & Board Certification
-
Professional Associations
Ayub Hussain, MD, FACG, FACP, is a Kelsey-Seybold Gastroenterology specialist who obtained his medical degree at Allama Iqbal Medical College in Lahore, Punjab, Pakistan, in 1987. Relocating to the United States, Dr. Hussain completed his internship and residency at Highland Hospital/University of Rochester in 1994 and 1996, respectively. He also completed fellowships at the University of Louisville, University of Rochester, and Alleghany General Hospital and joined Kelsey-Seybold in January 2024.
Dr. Hussain provides colon cancer screening as well as treatment and condition management for patients with GERD, inflammatory bowel disease, hepatitis, chronic liver disease and cirrhosis, Barrett's esophagus, GI bleeding, esophageal strictures, gallbladder disease, and Crohn's disease. He is also particularly interested in endoscopic procedures and ERCP, used to diagnose and treat conditions of the liver, gallbladder, pancreas, and bile ducts. Dr. Hussain’s favorite part of practicing medicine is diagnosing, treating, and improving quality of life for his patients.
Awards & Publications
Publications
- Infliximab in Refractory Ulcerative Colitis, The American Journal of Gastroenterology
- Ectopic Pancreatic Adenocancer Presenting as Gastric Obstruction, The American College of Gastroenterology
Research
- Dr. William Y. Chey, Ayub Hussain. Infliximab in Refractory Ulcerative Colitis. The American Journal of Gastroenterology, July 2001.
- Ectopic Pancreatic Adenocancer Presenting as Gastric Outlet Obstruction. The American College of Gastroenterology, October 2000.
- A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects with Severe Ulcerative Colitis (FIGAROUC301).
- A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects with Moderate to Severe Crohn’s Disease (CARMENCD307).
- Study Title: Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion 2018-07.
- Study Title: Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening.
- A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial of Oral IW-3718 Administered to Patients with Gastroesophageal Reflux Disease while receiving Proton Pump Inhibitors.
- A Phase 3 Randomized, Double-blind, Placebo controlled 52 Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderate to Severe Active Ulcerative Colitis (APD334-301).
- A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction Therapy in Subjects with Moderate to Severe active Crohn’s Disease.
Hobbies & Interests
When not caring for patients, Dr. Hussain enjoys spending time his three children, reading, watching movies, and watching Cricket matches.
Education
- Allama Iqbal Medical College, 1987
Internship/Residency
- Highland Hospital/University of Rochester, 1996
Board Certifications
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Gastroenterology
Dr. Hussain is a fellow of the American College of Physicians and the American College of Gastroenterology.
